Management of extravasations of enfortumab vedotin and pembrolizumab: a case report and mini review of the current literature
Hendrik Dinkel, Konstantin E. Seifert, Martin Bögemann, Andres J. Schrader, Katrin Schlack · 2026
Read Management of extravasations of enfortumab vedotin and pembrolizumab: a case report and mini review of the current literature by Hendrik Dinkel, Konstantin E. Seifert, Martin Bögemann, Andres J. Schrader, Katrin Schlack (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13675447.txt.
Description
Hendrik Dinkel and co-authors report the first case of a frontline bladder cancer drug pair leaking into tissue from a central port. Their 2026 case covers a 56-year-old patient whose port slipped from its vein during the first cycle. The drug pair is now standard first care for spread urothelial cancer.
The leak caused wide skin and tissue death below the collarbone. Surgery cleaned the wound, and a vacuum dressing aided slow secondary healing. The scar left no lasting pain or function loss. Therapy resumed through an arm vein and won a deep partial response. A mini review gathers prior leak reports. The authors warn that the drug cytotoxic payload makes leaks from this pair especially dangerous.
Catalog record
| CREATOR | Hendrik Dinkel, Konstantin E. Seifert, Martin Bögemann, Andres J. Schrader, Katrin Schlack |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |